Atlas Venture Fund X, L.P. - Jan 11, 2023 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role
10%+ Owner
Signature
Atlas Venture Fund X, L.P., By: Atlas Venture Associates X, L.P., its general partner, by Atlas Associates X, LLC, its general partner, By: /s/ Ommer Chohan, Ommer Chohan, Chief Financial Officer
Stock symbol
KYMR
Transactions as of
Jan 11, 2023
Transactions value $
-$3,821,739
Form type
4
Date filed
1/13/2023, 03:50 PM
Previous filing
Jan 3, 2023
Next filing
Aug 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KYMR Common Stock Sale -$650K -21.7K -0.43% $29.96 5.05M Jan 11, 2023 Direct F1, F2, F3
transaction KYMR Common Stock Sale -$182K -6.07K -0.66% $29.96 912K Jan 11, 2023 See footnote F1, F2, F4
transaction KYMR Common Stock Sale -$2.34M -77.1K -1.53% $30.29 4.97M Jan 12, 2023 Direct F1, F3, F5
transaction KYMR Common Stock Sale -$654K -21.6K -2.37% $30.29 890K Jan 12, 2023 See footnote F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.95 to $29.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (5).
F3 These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X"). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. ("AVA X LP"). Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. Each of AVA X LP and AVA X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of its pecuniary interest therein, if any.
F4 The shares are owned directly by Atlas Venture Opportunity Fund I, L.P. ("AVOF I"). Atlas Venture Associates Opportunity I, L.P. ("AVAO LP") is the general partner of AVOF I. Atlas Venture Associates Opportunity I, LLC ("AVAO LLC") is the general partner of AVAO LP. Each of AVAO LP and AVAO LLC disclaims Section 16 beneficial ownership of the securities held by AVOF I, except to the extent of its pecuniary interest therein, if any.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.95 to $30.65 inclusive.